---
document_datetime: 2023-09-21 18:26:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/plenadren-epar-all-authorised-presentations_en.pdf
document_name: plenadren-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9392361
conversion_datetime: 2025-12-26 09:05:17.247656
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form     | Route of Administra   | Immediate Packaging   | Pack size            |
|------------------|-------------------|------------|-------------------------|-----------------------|-----------------------|----------------------|
| EU/1/11/715/001  | Plenadren         | 5 mg       | Modified-release tablet | Oral use              | bottle (HDPE)         | 50 tablets           |
| EU/1/11/715/002  | Plenadren         | 20 mg      | Modified-release tablet | Oral use              | bottle (HDPE)         | 50 tablets           |
| EU/1/11/715/003  | Plenadren         | 5 mg       | Modified- tablet        | Oral use              | bottle (HDPE)         | 100 (2 x 50) tablets |
| EU/1/11/715/006  | Plenadren         | 20 mg      | Modified-release tablet | Oral use              | bottle (HDPE)         | 100 (2 x 50) tablets |